| Financial Year |
March 31 2023 |
| Monetary Funds |
3,885,580,709.53 |
| Held-for-trading Financial Assets |
423,607,191.13 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,636,952,345.22 |
| Advances to Suppliers |
54,460,134.09 |
| Other Receivables |
278,061,078.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
809,463.49 |
| Dividend Receivable |
-- |
| Inventories |
645,407,667.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
800,647,845.61 |
| Total Current Assets |
7,974,731,156.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,114,760.30 |
| Investment Properties |
566,617,291.50 |
| Fixed Assetes |
2,737,401,078.60 |
| Under-construction Projects |
265,056,195.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
830,060,438.30 |
| R&D expenses |
112,873,429.10 |
| Goodwill |
139,468,924.99 |
| Long-Term Deferred and Prepaid Expenses |
14,135,240.93 |
| Deferred Income Tax Assets |
92,745,746.61 |
| Other Non-Current Assets |
18,227,706.63 |
| Sub-Total of Non-Current Assets |
4,857,215,054.96 |
| Total Assets |
12,831,946,211.30 |
| Short-Term Loans |
340,385,985.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
428,668,413.12 |
| Accounts Payable |
1,815,253,258.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
120,706,913.87 |
| Taxes Payable |
138,869,520.17 |
| Interest Payable |
3,744,311.07 |
| Dividend Payable |
5,500,000.00 |
| Other payables |
756,870,058.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
58,865,146.79 |
| Other Current Liabilities |
22,084,382.53 |
| Sub-Total of Current Liabilities |
3,929,823,323.96 |
| Long-term Loans |
195,405,580.41 |
| Bonds Payable |
82,439,500.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
79,873,774.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
604,688,642.48 |
| Total Liabilities |
4,534,511,966.44 |
| Paid-In Capital(Or Share Stock) |
2,053,541,850.00 |
| Capital Surplus |
23,454,229.03 |
| Surplus Reserve |
573,053,244.27 |
| LESS:Treasury Stock |
6,079,668.71 |
| Undistributed Profits |
5,185,677,482.36 |
| Minority Stockholder's Interest |
300,007,669.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,997,426,575.23 |
| Owner's Equity（Stockholder's Equity） |
8,297,434,244.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,831,946,211.30 |
